Group 1 - Janus International Group, Inc. (JBI) shares have increased by 18.5% over the past four weeks, closing at $8.25, with a mean price target of $10.90 indicating a potential upside of 32.1% [1] - The mean estimate consists of five short-term price targets with a standard deviation of $2.97, where the lowest estimate is $7.50 (indicating a 9.1% decline) and the highest estimate is $14 (indicating a 69.7% increase) [2] - Analysts have shown strong agreement in revising earnings estimates higher, with the Zacks Consensus Estimate for the current year increasing by 35.4% over the last 30 days [11][12] Group 2 - JBI currently holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - The consensus price target, while not entirely reliable, suggests a positive direction for JBI's stock price movement [13] - Analysts' price targets can often be overly optimistic due to business incentives, which may lead to inflated estimates [8]

Core Viewpoint - Evolv Technologies Holdings, Inc. (EVLV) has shown a significant price increase of 30% over the past four weeks, with a mean price target of $7.06 indicating a potential upside of 29.3% from the current price of $5.46 [1] Price Targets and Analyst Estimates - The mean estimate consists of four short-term price targets with a standard deviation of $1.16, where the lowest estimate is $5.50 (0.7% increase) and the highest is $8.25 (51.1% increase) [2] - A low standard deviation suggests a strong agreement among analysts regarding the stock's price movement, which can serve as a starting point for further research [9] Earnings Estimates and Analyst Agreement - There is a growing optimism among analysts about EVLV's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which correlates with potential stock price increases [11] - The Zacks Consensus Estimate for the current year has risen by 23.3% over the past month, with no negative revisions reported [12] Zacks Rank and Investment Potential - EVLV holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for upside in the near term [13]

Core Viewpoint - Crexendo (CXDO) shows potential for significant upside, with a mean price target of $8.30 indicating a 55.1% increase from the current trading price of $5.35 [1] Price Targets and Analyst Estimates - The mean estimate consists of five short-term price targets with a standard deviation of $0.97, suggesting variability in analyst predictions [2] - The lowest estimate of $7.50 indicates a 40.2% increase, while the highest estimate suggests an 86.9% surge to $10 [2] - A low standard deviation indicates strong agreement among analysts regarding the stock's price direction [9] Analyst Sentiment and Earnings Estimates - Analysts have shown increasing optimism about CXDO's earnings prospects, as evidenced by a positive trend in earnings estimate revisions [11] - The Zacks Consensus Estimate for the current year has risen by 18.2% over the past month, with two estimates increasing and no negative revisions [12] - CXDO holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13]

Core Viewpoint - Arvinas, Inc. (ARVN) shows significant upside potential with a mean price target of $14.62, indicating a 94.9% increase from the current price of $7.50 [1] Price Targets and Estimates - The mean estimate consists of 17 short-term price targets with a standard deviation of $5.19, suggesting variability in analyst predictions [2] - The lowest estimate of $8 indicates a 6.7% increase, while the highest estimate suggests a 233.3% surge to $25 [2] - A low standard deviation indicates strong agreement among analysts regarding the stock's price movement [9] Analyst Sentiment and Earnings Estimates - Analysts have shown increasing optimism about ARVN's earnings prospects, as evidenced by a positive trend in earnings estimate revisions [11] - The Zacks Consensus Estimate for the current year has risen by 56.9% over the past month, with 11 estimates increasing and one decreasing [12] - ARVN holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13]

Core Viewpoint - Werewolf Therapeutics, Inc. (HOWL) has been upgraded to a Zacks Rank 2 (Buy), indicating a positive outlook based on rising earnings estimates, which significantly influence stock prices [1][3]. Earnings Estimates and Stock Price Movement - The Zacks rating system emphasizes the correlation between changes in earnings estimates and stock price movements, making it a valuable tool for investors [2][4]. - An increase in earnings estimates typically leads to higher fair value calculations by institutional investors, resulting in buying or selling pressure that affects stock prices [4]. Company Performance and Investor Sentiment - The upgrade reflects an improvement in Werewolf Therapeutics' underlying business, which is expected to drive stock appreciation as investors recognize this positive trend [5]. - Over the past three months, the Zacks Consensus Estimate for Werewolf Therapeutics has increased by 6.6%, indicating a positive revision trend [8]. Zacks Rank System - The Zacks Rank system classifies stocks based on earnings estimate revisions, with only the top 20% of stocks receiving a 'Strong Buy' or 'Buy' rating, suggesting a strong potential for market-beating returns [9][10]. - The upgrade of Werewolf Therapeutics to a Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, indicating a favorable position for potential stock price increases in the near term [10].

Core Viewpoint - Freightos Limited (CRGO) has received an upgrade to a Zacks Rank 2 (Buy) due to an upward trend in earnings estimates, which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Price Movement - The Zacks rating system is based on changes in earnings estimates, which are closely correlated with near-term stock price movements [4][6]. - Institutional investors often rely on earnings estimates to determine the fair value of a company's shares, leading to buying or selling actions that affect stock prices [4]. Company Performance Indicators - The recent upgrade for Freightos Limited indicates an improvement in the company's underlying business, suggesting that investors may push the stock price higher [5]. - Analysts have raised their earnings estimates for Freightos Limited, with the Zacks Consensus Estimate increasing by 2.9% over the past three months [8]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a strong historical performance, particularly for Zacks Rank 1 stocks, which have generated an average annual return of +25% since 1988 [7]. - Freightos Limited's upgrade to Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, indicating a strong potential for market-beating returns in the near term [10].

Group 1 - AudioEye (AEYE) shares have increased by 15.7% over the past four weeks, closing at $12.55, with a mean price target of $22.40 indicating a potential upside of 78.5% [1] - The average price targets range from a low of $20 to a high of $25, with a standard deviation of $2.51, suggesting a potential increase of 59.4% to 99.2% from the current price level [2] - Analysts show strong agreement in revising earnings estimates higher, which correlates with potential stock price movements, as the Zacks Consensus Estimate for the current year has increased by 10.4% [11][12] Group 2 - AEYE holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating a strong potential upside [13] - While price targets are often viewed skeptically due to their tendency to mislead investors, a tight clustering of targets with low standard deviation suggests a high degree of agreement among analysts regarding price movement [9][10]

Core Viewpoint - Easterly Government Properties (DEA) has shown an 8.1% gain over the past four weeks, with a mean price target of $28.25 indicating a potential upside of 29.6% from the current price of $21.80 [1] Price Targets and Analyst Estimates - The mean estimate consists of five short-term price targets with a standard deviation of $3.26, where the lowest estimate is $23.75 (8.9% increase) and the highest is $32.50 (49.1% increase) [2] - A low standard deviation among price targets suggests a high degree of agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Market Sentiment - Analysts have shown increasing optimism about DEA's earnings prospects, as indicated by a strong consensus in revising EPS estimates higher, which correlates with potential stock price increases [11] - Over the last 30 days, one estimate has moved higher with no negative revisions, leading to a 0.8% increase in the Zacks Consensus Estimate for the current year [12] Zacks Rank and Investment Potential - DEA holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating a strong potential for upside in the near term [13]

Avadel (AVDL) closed the last trading session at $9.05, gaining 1.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $17.89 indicates a 97.7% upside potential.The mean estimate comprises nine short-term price targets with a standard deviation of $3.79. While the lowest estimate of $12 indicates a 32.6% increase from the current price level, the most optimistic analyst expects the s ...

Core Viewpoint - Kemper (KMPR) has shown a 6.1% increase in stock price over the past four weeks, with a mean price target of $82.20 indicating a potential upside of 31% from the current price of $62.75 [1] Price Targets - The average price target consists of five estimates ranging from a low of $75 to a high of $90, with a standard deviation of $5.72, suggesting a variability in analyst estimates [2] - The lowest estimate indicates a 19.5% increase, while the highest suggests a 43.4% upside [2] Analyst Sentiment - Analysts are optimistic about KMPR's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which historically correlates with stock price movements [4][11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 5.1%, with three estimates moving higher and no negative revisions [12] Zacks Rank - KMPR holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [13]